News

Filter

Current filters:

None

151 to 160 of 97887 results

Positive Ph III results for Navidea’s Lymphoseek in head and neck cancer

17-02-2015

US biotech firm Navidea Biopharmaceuticals today announced positive peer-reviewed publication of results…

BiotechnologyLymphoseekNavidea BiopharmaceuticalsOncologyResearch

FDA conference highlights: Agency focuses on pediatric therapies to treat rare diseases

FDA conference highlights: Agency focuses on pediatric therapies to treat rare diseases

17-02-2015

In a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks the…

FDAPharmaceuticalPharmacologyRegulationUSA

Takeda motesanib fails to meet primary endpoint in Ph III NSCLC study

Takeda motesanib fails to meet primary endpoint in Ph III NSCLC study

17-02-2015

In a second research negative this month, Japan’s largest drugmaker Takeda Pharmaceutical has today…

JapanmotesanibOncologyPharmaceuticalResearchTakeda Pharmaceutical

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

17-02-2015

UK pharma major GlaxoSmithKline has named Jack Bailey as president of its US pharma unit.

BoardroomGSKPharmaceuticalUnited StatesUSA

Australia to subsidize Genzyme’s Pompe disease drug Myozyme for young patients

Australia to subsidize Genzyme’s Pompe disease drug Myozyme for young patients

17-02-2015

Australia’s Minister for Health Sussan Ley said today that she has approved a life-saving drug that…

AustraliaBiotechnologyFinancialGenzymeHealthcareMyozymeRare diseasesSanofi

US Orphan Drug status for Bexion’s Saposin C for glioblastoma

US Orphan Drug status for Bexion’s Saposin C for glioblastoma

17-02-2015

Privately-held US biotech firm Bexion Pharmaceuticals has received Orphan Drug designation for the US…

Bexion PharmaceuticalsBiotechnologyBXQ-350OncologyRegulationSaposin CUSA

Fresenius Kabi sells German oncology compounding business

Fresenius Kabi sells German oncology compounding business

17-02-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has sold its German subsidiary CFL…

CFLFreseniusFresenius KabiGermanyMergers & AcquisitionsNewCo PharmaOncologyPharmaceutical

Biotie receives positive opinion on orphan drug status for BTT1023 from EMA

Biotie receives positive opinion on orphan drug status for BTT1023 from EMA

17-02-2015

Finnish biotech and pharma company Biotie has received a positive opinion from the European Medicines…

BiotechnologyBiotie TherapiesFinlandNephrology and HepatologyRegulation

Call for transitional arrangements for Australia’s R&D Tax incentive cap

Call for transitional arrangements for Australia’s R&D Tax incentive cap

17-02-2015

The passage of unwelcome legislation last week to cap claims on the Australian Research and Development…

AustraliaBiotechnologyFinancialPoliticsResearch

151 to 160 of 97887 results

COMPANY SPOTLIGHT

Menarini

Back to top